loader image
Friday, December 19, 2025
65.2 F
McAllen
- Advertisement -

Health Commissioner: We Are at a CRITICAL POINT

Translate to Spanish or other 102 languages!

Image for illustration purposes.

Mega Doctor News

- Advertisement -

Legislators had a call with Texas Department of State Health Services Commissioner John Hellerstedt to discuss COVID-19. He made it very clear we are again at a CRITICAL point. We are seeing a surge of COVID cases and hospitalizations across the nation, and Texas is NO EXCEPTION

The Delta variant is more transmissible, more deadly, and individuals with underlying vulnerabilities are at higher risk of severe infection and death. 95-99% of those currently hospitalized are unvaccinated. The slides below prove that the vaccine works.

We cannot eliminate this terrible and deadly disease without more individuals in our state getting the vaccine. If you have not gotten the vaccine, please get one as soon as possible. The vaccine not only protects you, it protects all of us.

- Advertisement -

Help us put COVID behind us. Find a COVID-19 vaccine near you by clicking on this link, www.vaccines.gov.

Increases in COVID-19 Hospitalizations
Increases in Pediatric Hospitalizations
 
Vaccination Decreases Hospitalizations
Vaccination Decreases Mortality
Conclusions
Vaccination Rates in SD 20

All images courtesy of Texas Health and Human Services.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

FDA Approves Daily Pill to Treat Low Libido in Women After Menopause

On December 15, 2025, the U.S. Food and Drug Administration (FDA) approved the medication Addyi (flibanserin) for the treatment of hypoactive sexual desire disorder (HSDD) in postmenopausal women under the age of 65.

Heart Association Highlights 2025’s Major Research Findings

In 2025, cardiovascular investigators worldwide reported findings that could help fill important gaps in preventing and managing conditions including high blood pressure, stroke, heart failure, dangerous blood clots and aortic stenosis.

DHR Health and Brownsville Join Forces on Major Hospital Expansion

The City of Brownsville and DHR Health announced a new public-private partnership to expand DHR Health Brownsville, marking a major investment in local healthcare and economic development

Uniting Experts to Revolutionize Cancer Treatment

More than 70% of all cancers are impacted by mutations caused by a group of DNA-editing enzymes that drives tumor growth and drug resistance. The apolipoprotein B mRNA-editing enzyme catalytic polypeptide, or APOBEC, family, is a dominant factor in many cancers including bladder, breast, cervical, head and neck and lung.
- Advertisement -
×